Patents by Inventor Terrance W. Ocheltree

Terrance W. Ocheltree has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220008352
    Abstract: A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl.
    Type: Application
    Filed: September 23, 2021
    Publication date: January 13, 2022
    Applicant: KINDEVA DRUG DELIVERY L.P.
    Inventors: Adam S. Cantor, Terrance W. Ocheltree, Cynthia A. Robles
  • Publication number: 20200253887
    Abstract: A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl.
    Type: Application
    Filed: April 29, 2020
    Publication date: August 13, 2020
    Inventors: Adam S. Cantor, Terrance W. Ocheltree, Cynthia A. Robles
  • Publication number: 20200000739
    Abstract: A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl.
    Type: Application
    Filed: September 6, 2019
    Publication date: January 2, 2020
    Inventors: Adam S. Cantor, Terrance W. Ocheltree, Cynthia A. Robles
  • Publication number: 20190167603
    Abstract: A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl.
    Type: Application
    Filed: February 8, 2019
    Publication date: June 6, 2019
    Inventors: Adam S. Cantor, Terrance W. Ocheltree, Cynthia A. Robles
  • Publication number: 20180153823
    Abstract: A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl.
    Type: Application
    Filed: January 26, 2018
    Publication date: June 7, 2018
    Inventors: Adam S. Cantor, Terrance W. Ocheltree, Cynthia A. Robles
  • Publication number: 20170296486
    Abstract: A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl.
    Type: Application
    Filed: June 30, 2017
    Publication date: October 19, 2017
    Inventors: Adam S. Cantor, Terrance W. Ocheltree, Cynthia A. Robles
  • Publication number: 20170035704
    Abstract: A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl.
    Type: Application
    Filed: October 20, 2016
    Publication date: February 9, 2017
    Inventors: Adam S. Cantor, Terrance W. Ocheltree, Cynthia A. Robles
  • Publication number: 20160184235
    Abstract: A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl.
    Type: Application
    Filed: March 9, 2016
    Publication date: June 30, 2016
    Inventors: Adam S. Cantor, Terrance W. Ocheltree, Cynthia A. Robles
  • Publication number: 20150313851
    Abstract: A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl.
    Type: Application
    Filed: July 15, 2015
    Publication date: November 5, 2015
    Inventors: Adam S. Cantor, Terrance W. Ocheltree, Cynthia A. Robles
  • Publication number: 20150025480
    Abstract: A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl.
    Type: Application
    Filed: October 7, 2014
    Publication date: January 22, 2015
    Inventors: Adam S. Cantor, Terrance W. Ocheltree, Cynthia A. Robles
  • Publication number: 20140170206
    Abstract: A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl.
    Type: Application
    Filed: February 25, 2014
    Publication date: June 19, 2014
    Applicant: 3M Innovative Properties Company
    Inventors: Adam S. Cantor, Terrance W. Ocheltree, Cynthia A. Robles
  • Publication number: 20130295158
    Abstract: A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl.
    Type: Application
    Filed: July 9, 2013
    Publication date: November 7, 2013
    Inventors: Adam S. Cantor, Terrance W. Ocheltree, Cynthia A. Robles
  • Publication number: 20120034292
    Abstract: A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl.
    Type: Application
    Filed: October 18, 2011
    Publication date: February 9, 2012
    Inventors: Adam S. Cantor, Terrance W. Ocheltree, Cynthia A. Robles
  • Publication number: 20110038918
    Abstract: A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl.
    Type: Application
    Filed: August 6, 2010
    Publication date: February 17, 2011
    Inventors: Adam S. Cantor, Terrance W. Ocheltree, Cynthia A. Robles
  • Publication number: 20100255073
    Abstract: A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl.
    Type: Application
    Filed: June 22, 2010
    Publication date: October 7, 2010
    Inventors: Adam S. Cantor, Terrance W. Ocheltree, Cynthia A. Robles
  • Publication number: 20020119187
    Abstract: A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl.
    Type: Application
    Filed: September 26, 2001
    Publication date: August 29, 2002
    Inventors: Adam S. Cantor, Terrance W. Ocheltree, Cynthia A. Robles